Glamsmile Opens Rome Studio, With the Wenzhou Studio Opening to Follow Shortly Thereafter
October 11 2011 - 9:04AM
Marketwired
Remedent, Inc. (OTCBB: REMI) an international company specializing
in research, development, and the manufacturing of oral care and
cosmetic dentistry, opened another Studio in Rome yesterday.
"We are all excited about opening our largest European Studio in
Rome yesterday. Rome is one of the major cities of Europe with a
population of about 3 million people which relates to about ten
times the size of Ghent, our world headquarters. The studio is
based in a very affluent part of Rome, not far from the Spanish
steps.
For opening week, we already have 4 cases to seat which is an
encouraging start to our business in this great capital of the
world. The initial responses we have received via our marketing
program for Rome and the outlying areas has been very encouraging
to say the least.
"We also anticipate that our Studio located in Wenzhou, China
will open very soon once the final inspection has been completed.
Wenzhou is the birthplace of China's private economy and has a
population in excess of 9 million people. In addition to Wenzhou,
we are applying for two new leases in greater China pursuant to our
plan to expand our Asian Studio operations based on our prior
success in Hong Kong, Shanghai and Beijing," said Guy De Vreese,
CEO of Remedent.
About Remedent: Remedent Inc. specializes in the research,
development, manufacturing and the marketing of oral care and
cosmetic dental products. The company serves the professional
dental industry with breakthrough technology for dental veneers.
These products are supported by a line of professional veneer
whitening and tooth sensitivity solutions. Headquartered in
Belgium, Remedent distributes its products to more than 55
countries world-wide. For more information, go to www. Remedent.be,
glamsmile.be and glamsmile.cn
Forward Looking Statements:
Statements in this press release that are "forward looking
statement" are based on current expectations that are subject to
risks and uncertainties. Such forward looking statements involve
known and unknown risks, uncertainties and other unknown factors
that could cause Remedent's actual results to be materially
different from any historical results or from any future results
express or implied by such forward looking statements. In addition
to these statements that explicitly describe these risks and
uncertainties, readers are urged to consider statements that
contain terms such as "believes," "belief," "expects," "intends,"
intend," "anticipate, " "anticipates," "plans," "plan," "projects,"
"project," to be uncertain and forward-looking. Actual results
could differ materially because of the factors such as Remedent's
ability to achieve the value creation and the results of operations
as contemplated by its business plan and objectives, and the risks
related to expansion and growth. For further information regarding
risks and uncertainties, associated with Remedent's business,
please refer to the risk factors described in Remedent's filings
with the Securities and Exchange Commission, including but not
limited to its annual report on Form 10-K and the quarterly reports
on 10-Q. We undertake no duty to revise or update any
forward-looking statements to reflect events or circumstances after
the date of this press release.
Contact information: Stephen Ross 310 922-5685
Docktor99@aol.com
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2024 to Aug 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Aug 2023 to Aug 2024